Bristol-Myers Squibb Co (BMY)
55.22
+0.90
(+1.66%)
USD |
NYSE |
Nov 04, 13:15
Bristol-Myers Squibb Market Cap: 112.00B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 110.17B |
| October 31, 2024 | 113.11B |
| October 30, 2024 | 106.80B |
| October 29, 2024 | 106.48B |
| October 28, 2024 | 106.76B |
| October 25, 2024 | 105.30B |
| October 24, 2024 | 107.33B |
| October 23, 2024 | 107.63B |
| October 22, 2024 | 107.02B |
| October 21, 2024 | 105.72B |
| October 18, 2024 | 107.95B |
| October 17, 2024 | 107.87B |
| October 16, 2024 | 108.26B |
| October 15, 2024 | 107.02B |
| October 14, 2024 | 106.84B |
| October 11, 2024 | 105.88B |
| October 10, 2024 | 106.29B |
| October 09, 2024 | 107.10B |
| October 08, 2024 | 106.45B |
| October 07, 2024 | 108.40B |
| October 04, 2024 | 109.45B |
| October 03, 2024 | 109.94B |
| October 02, 2024 | 109.05B |
| October 01, 2024 | 107.30B |
| September 30, 2024 | 104.95B |
| Date | Value |
|---|---|
| September 27, 2024 | 103.21B |
| September 26, 2024 | 101.61B |
| September 25, 2024 | 101.27B |
| September 24, 2024 | 103.28B |
| September 23, 2024 | 101.39B |
| September 20, 2024 | 100.17B |
| September 19, 2024 | 99.38B |
| September 18, 2024 | 100.84B |
| September 17, 2024 | 100.34B |
| September 16, 2024 | 101.35B |
| September 13, 2024 | 99.61B |
| September 12, 2024 | 97.80B |
| September 11, 2024 | 98.51B |
| September 10, 2024 | 99.91B |
| September 09, 2024 | 98.33B |
| September 06, 2024 | 98.73B |
| September 05, 2024 | 100.96B |
| September 04, 2024 | 101.29B |
| September 03, 2024 | 102.42B |
| August 30, 2024 | 101.27B |
| August 29, 2024 | 100.80B |
| August 28, 2024 | 99.46B |
| August 27, 2024 | 97.56B |
| August 26, 2024 | 97.80B |
| August 23, 2024 | 97.54B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
80.39B
Minimum
Jul 05 2024
172.50B
Maximum
Dec 02 2022
133.10B
Average
137.94B
Median
Jun 02 2023
Market Cap Benchmarks
| Amgen Inc | 170.48B |
| Johnson & Johnson | 382.40B |
| Eli Lilly and Co | 767.34B |
| Merck & Co Inc | 256.60B |
| Pfizer Inc | 157.96B |
Market Cap Related Metrics
| PS Ratio | 2.362 |
| Price to Book Value | 6.533 |
| Price to Free Cash Flow | 8.117 |
| Price | 55.22 |
| Earnings Yield | -6.50% |
| Operating PE Ratio | 15.39 |
| Normalized PE Ratio | 34.59 |